Neto B, Tavares V, Santos J, Cerqueira F, Pereira D, Medeiros R
Discov Oncol. 2023; 14(1):3.
PMID: 36617364
PMC: 9826626.
DOI: 10.1007/s12672-022-00610-1.
Nagase K, Narisawa Y
Curr Treat Options Oncol. 2018; 19(11):57.
PMID: 30238195
DOI: 10.1007/s11864-018-0574-5.
Stakaityte G, Nwogu N, Dobson S, Knight L, Wasson C, Salguero F
J Virol. 2017; 92(2).
PMID: 29093086
PMC: 5752956.
DOI: 10.1128/JVI.00940-17.
Ritter C, Fan K, Paschen A, Reker Hardrup S, Ferrone S, Nghiem P
Sci Rep. 2017; 7(1):2290.
PMID: 28536458
PMC: 5442125.
DOI: 10.1038/s41598-017-02608-0.
Nghiem P, Kaufman H, Bharmal M, Mahnke L, Phatak H, Becker J
Future Oncol. 2017; 13(14):1263-1279.
PMID: 28350180
PMC: 6040046.
DOI: 10.2217/fon-2017-0072.
Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma.
Wahl R, Braunschweig T, Ghassemi A, Rubben A
Curr Oncol. 2016; 23(2):e150-3.
PMID: 27122984
PMC: 4835010.
DOI: 10.3747/co.23.2878.
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.
Saini A, Miles B
Onco Targets Ther. 2015; 8:2157-67.
PMID: 26316785
PMC: 4548751.
DOI: 10.2147/OTT.S72202.
The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer.
Moens U, Rasheed K, Abdulsalam I, Sveinbjornsson B
Viruses. 2015; 7(4):1871-901.
PMID: 25866902
PMC: 4411681.
DOI: 10.3390/v7041871.
[Merkel cell carcinoma].
Kleffner F, Schurholz J, Burckhardt S, Mauch C, Schlaak M
Hautarzt. 2014; 65(9):823-30.
PMID: 25234632
DOI: 10.1007/s00105-014-2854-8.
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Paulson K, Tegeder A, Willmes C, Iyer J, Afanasiev O, Schrama D
Cancer Immunol Res. 2014; 2(11):1071-9.
PMID: 25116754
PMC: 4221542.
DOI: 10.1158/2326-6066.CIR-14-0005.
Merkel cell carcinoma in immunosuppressed patients.
Ma J, Brewer J
Cancers (Basel). 2014; 6(3):1328-50.
PMID: 24978436
PMC: 4190543.
DOI: 10.3390/cancers6031328.
Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus.
Stakaityte G, Wood J, Knight L, Abdul-Sada H, Adzahar N, Nwogu N
Cancers (Basel). 2014; 6(3):1267-97.
PMID: 24978434
PMC: 4190541.
DOI: 10.3390/cancers6031267.
Merkel Cell Carcinoma: Epidemiology, Target, and Therapy.
Hughes M, Hardee M, Cornelius L, Hutchins L, Becker J, Gao L
Curr Dermatol Rep. 2014; 3:46-53.
PMID: 24587977
PMC: 3931972.
DOI: 10.1007/s13671-014-0068-z.
The role of the immune response in merkel cell carcinoma.
Triozzi P, Fernandez A
Cancers (Basel). 2013; 5(1):234-54.
PMID: 24216706
PMC: 3730301.
DOI: 10.3390/cancers5010234.
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.
Desch L, Kunstfeld R
J Skin Cancer. 2013; 2013:327150.
PMID: 23476782
PMC: 3582102.
DOI: 10.1155/2013/327150.
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.
Miller N, Bhatia S, Parvathaneni U, Iyer J, Nghiem P
Curr Treat Options Oncol. 2013; 14(2):249-63.
PMID: 23436166
PMC: 3651762.
DOI: 10.1007/s11864-013-0225-9.
